Mark Angelino

Mark Angelino

Directeur/Bestuurslid bij Arbor Biotechnologies, Inc.

51 jaar
Health Technology
Finance
Commercial Services

Profiel

Mark joined TRV as a venture partner in 2021.
He most recently served as Chief Operating Officer at Generation Bio (a non-viral, genetics medicine company), which he co-founded in 2016.
From 2012 to 2016, Mark was on the leadership team at bluebird bio, as senior vice president of pharmaceutical sciences and rare disease franchise head.
These two experiences combining novel therapeutic approaches and early builds is what drew Mark to Third Rock and its patient-centric mission.
Prior to that, at companies like Baxter Healthcare, Archemix, Millennium and DuPont Pharma, Mark acquired broad operational experience that cut across multiple modalities (small-molecules, ADCs, biologics, peptides, oligonucleotides, complex mixtures, and gene therapies), as well as across various stages of therapeutic development- from early translation to product launches.
He also currently serves on the Board of Directors of Arbor Biotechnologies.

Actieve functies van Mark Angelino

BedrijvenFunctieBegin
Directeur/Bestuurslid 03-03-2021
Private Equity Investor 01-03-2021
Alle actieve functies van Mark Angelino

Eerdere bekende functies van Mark Angelino

BedrijvenFunctieEinde
GENERATION BIO CO. Oprichter 01-02-2021
BLUEBIRD BIO, INC. Corporate Officer/Principal 01-10-2016
Private Equity Investor 01-05-2012
Corporate Officer/Principal 01-12-2010
Corporate Officer/Principal -
Ervaring van Mark Angelino in detail bekijken

Opleiding van Mark Angelino

Massachusetts Institute of Technology Doctorate Degree
The Cooper Union for the Advancement of Science & Art Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mark Angelino in detail bekijken

Connecties

100 +

Eerstegraads connecties

12

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven3
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

GENERATION BIO CO.

Health Technology

BLUEBIRD BIO, INC.

Health Technology

Bedrijven in privébezit7

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Producer Manufacturing

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Mark Angelino
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU